Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Genfit | EU:GNFT | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.025 | 69,353 | 09:53:12 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 4.025 | 4.045 | 4.08 | 4.00 | 4.025 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 38.68M | -28.89M | -0.5798 | -6.95 | 200.59M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:53:12 | 2 | 4.025 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/11/2024 | 21:10 | UKREG | GENFIT fait un point d’actualité sur ses activités à l’occasion de sa.. |
| 13/11/2024 | 21:10 | UKREG | GENFIT Announces Corporate Updates and Upcoming Participation at The Liver.. |
| 07/11/2024 | 21:10 | UKREG | GENFIT Reports Third Quarter 2024 Financial Information |
| 07/11/2024 | 21:10 | UKREG | GENFIT : Information financière du troisième trimestre 2024 |
| 23/9/2024 | 05:30 | UKREG | GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que.. |
| 23/9/2024 | 05:30 | UKREG | GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a.. |
| 19/9/2024 | 20:10 | UKREG | GENFIT : Résultats financiers du premier semestre 2024 et point sur les.. |
| 19/9/2024 | 20:10 | UKREG | GENFIT Reports First Half-Year 2024 Financial Results and Provides.. |
| 26/7/2024 | 11:45 | UKREG | GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo®.. |
| 26/7/2024 | 11:45 | UKREG | GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour.. |
Genfit (GNFT) Share Charts1 Year Genfit Chart |
|
1 Month Genfit Chart |
Intraday Genfit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
